시장보고서

상품코드

1463649

아시아태평양 대동맥판막 치환술 기기 시장 : 지역 분석 - 제품별, 수술별, 최종 사용자별 예측(-2030년)

Asia Pacific Aortic Valve Replacement Devices Market Forecast to 2030 - Regional Analysis - by Product, Surgery, and End User .

발행일: 2024년 01월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 87 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

아시아태평양 대동맥판막 치환술 기기 시장은 2022년 13억 2,315만 달러에서 2030년에는 34억 8,938만 달러로 성장할 것으로 예측됩니다. 예측기간 동안 복합 연간 성장률(CAGR) 12.9%로 추정됩니다.

대동맥판막 치환술 기기의 진보가 아시아태평양 대동맥판막 치환술 기기 시장을 뒷받침

경 카테터 대동맥판막 치환술(TAVR)과 같은 저침습 수술 절차(MIS)의 개발은 대동맥 판막 협착증(AS)의 치료를 현대화하였습니다. 경 카테터 대동맥판막 치환술은 종래의 개심술보다 침습이 적기 때문에 지금까지 수술의 대상이 되지 않았던 고위험의 환자에서도 치료를 받게 되었습니다. 게다가, 재료와 디자인의 개발은 더 튼튼하고 생체적합성이 높은 대동맥판막 치환술을 개발하여 환자의 예후를 개선하고 합병증의 위험을 감소시킵니다.

대동맥판막 치환술 기기의 기업에 의한 몇 가지 기술적 진보는 다음과 같습니다.

2023년 1월, Abbot사는 개심술 위험이 높은 심각한 대동맥 판막 협착증 환자를 치료하기 위한 경 카테터 대동맥 판막 유치(TAVI) 시스템 '나비톨'의 FDA 승인을 받았습니다. Navitol은 Abbott의 광범위한 경경 카테터 구조 심장 포트폴리오에 참가한 최신 제품으로 의사와 환자에게 다양한 심각한 심장 질환에 대한 침습이 적은 치료 옵션을 제공합니다.

2021년 9월, Abbot은 대동맥 판막과 승모판 질환 환자의 치료 옵션을 개선하기 위해 Epic Plus 및 Epic Plus Supra Stented Tissue Valves의 FDA 승인을 받았습니다. 이 새로운 장치로 Abbot은 에픽 수술용 밸브 플랫폼을 확장했습니다.

2021년 8월, 첸나이 최초의 인도 3D 프린팅 심장 밸브가 개발되었습니다. 새로운 심장 밸브는 3D 프린터를 사용하여 개발되었으며 인공 심장 밸브와 관련된 문제를 극복 할 수있었습니다. 따라서, 기술의 진보는 대동맥판막 치환술 기기 시장에 유리한 기회를 창출하고 있습니다.

아시아태평양 대동맥판막 치환술 기기 시장 개요

아시아태평양 대동맥판막 치환술 기기 시장은 중국, 일본, 인도, 호주, 한국 및 기타 아시아태평양으로 구분됩니다. 이 지역은 세계 대동맥판막 치환술 기기 시장에서 큰 점유율을 차지합니다. 아시아태평양 시장은 노인 인구 증가, 심혈관 질환 증가, 혁신적인 제품 가용성 등의 요인으로 인해 예측 기간 동안 큰 성장이 예상됩니다.

아시아태평양 대동맥판막 치환술 기기 시장 수익과 예측(-2030년)(금액)

아시아태평양 대동맥판막 치환술 기기 시장의 세분화

아시아태평양 대동맥판막 치환술 기기 시장은 제품, 수술, 최종 사용자 및 국가별로 분류됩니다.

제품별로, 아시아태평양 대동맥판막 치환술 기기 시장은 무봉합 밸브와 기계식 밸브로 구분됩니다. 2022년 아시아태평양 대동맥판막 치환술 기기 시장은 무봉합 밸브가 큰 점유율을 차지하고 있습니다.

수술을 바탕으로 아시아태평양 대동맥판막 치환술 기기 시장은 낮은 침습 수술과 개복 수술로 나뉩니다. 2022년에는 낮은 침습 수술 부문이 아시아태평양 대동맥판막 치환술 기기 시장에서 더 큰 점유율을 차지했습니다.

최종 사용자를 기반으로 아시아태평양 대동맥판막 치환술 기기 시장은 병원 및 클리닉, 외래수술센터(ASC) 및 기타로 분할됩니다. 병원 및 클리닉 부문은 2022년 아시아태평양 대동맥판막 치환술 기기 시장 점유율에서 최대를 차지합니다.

국가별로 볼 때 아시아태평양 대동맥판막 치환술 기기 시장은 중국, 일본, 인도, 호주, 한국 및 기타 아시아태평양으로 분류됩니다. 중국은 2022년 아시아태평양 대동맥판막 치환술 기기 시장을 독점했습니다.

Abbott Laboratories, Artivion Inc, Boston Scientific Corp, Edwards Lifesciences Corp, LivaNova Plc, Medtronic Plc, Venus MedTech HangZhou Inc.

주요 시장 성장 촉진요인
- 대동맥판 치환 수술 건수 증가
- 저침습 기술에 대한 수요 증가
시장 성장 억제요인
- 제품 리콜
- 심장구조장치에 관한 엄격한 규제
시장 기회
- 대동맥판막 치환술 기기의 진보
향후의 동향
- 임상 연구 증가
영향 분석

제6장 대동맥판막 치환술 기기 시장 : 아시아태평양 시장 분석

아시아태평양 대동맥판막 치환술 기기 시장 수익(2022년-2030년)

제7장 아시아태평양 대동맥판막 치환술 기기 시장 - 수익과 예측(-2030년) : 제품별

시장수익 점유율(2022년, 2030년)
메카니컬 밸브
무봉합밸브

제8장 아시아태평양 대동맥판막 치환술 기기 시장 - 수익과 예측(-2030년) : 수술별

시장수익 점유율(2022년, 2030년)
개복 수술
저침습 수술

제9장 아시아태평양 대동맥판막 치환술 기기 시장 - 수익과 예측(-2030년) : 최종 사용자별

시장수익 점유율(2022년, 2030년)
병원 및 클리닉
외래수술센터(ASC)
기타

제10장 아시아태평양 대동맥판막 치환술 기기 시장 : 국가별 분석

아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 기타 아시아태평양

제11장 아시아태평양 대동맥판막 치환술 기기 시장의 업계 정세

아시아태평양 대동맥판막 치환술 기기 시장의 성장 전략
유기적 성장 전략
무기적 성장 전략

제12장 주요 기업 프로파일

Abbott Laboratories
Medtronic Plc
Boston Scientific Corp
LivaNova Plc
Edwards Lifesciences Corp
Artivion Inc
Venus MedTech HangZhou Inc

제13장 부록

BJH 24.05.23

The Asia Pacific aortic valve replacement devices market is expected to grow from US$ 1,323.15 million in 2022 to US$ 3,489.38 million by 2030. It is estimated to grow at a CAGR of 12.9% from 2022 to 2030.

Advancements in Aortic Valve Replacement Devices Fuels Asia Pacific Aortic Valve Replacement Devices Market

The development of minimally invasive surgical techniques (MIS), such as transcatheter aortic valve replacement (TAVR), has modernized the treatment of aortic stenosis (AS). Transcatheter aortic valve replacement is less invasive than traditional open-heart surgery, making it possible for high-risk patients who may not have been eligible for surgery to receive treatment. Moreover, developments in materials and design have led to the development of stronger and biocompatible aortic valve replacements, which have improved patient outcomes and reduced the risk of complications.

A few technological advancements by the players in the aortic valve replacement devices are mentioned below:

In January 2023, Abbott received FDA approval for the Navitor transcatheter aortic valve implantation (TAVI) system to treat people with severe aortic stenosis at high risk of open-heart surgery. Navitor is the latest addition to the company's extensive transcatheter structural heart portfolio, which offers physicians and patients less invasive treatment options for a range of serious heart diseases.

In September 2021, Abbott received FDA approval for its Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. With this new device, Abbott expanded its Epic surgical valve platform.

In August 2021, the first Made in India 3D printed heart valve was developed in Chennai. The new heart valves were developed using 3D printers, which could overcome the problems related to artificial heart valves. Therefore, technological advancements are creating lucrative opportunities in the aortic valve replacement devices market.

Asia Pacific Aortic Valve Replacement Devices Market Overview

The Asia Pacific aortic valve replacement devices market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The region holds a significant share of the global aortic valve replacement devices market. The market in Asia Pacific is expected to witness significant growth during the forecast period due to factors such as rising elderly population, growing cardiovascular diseases, and innovative product availability.

Asia Pacific Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Aortic Valve Replacement Devices Market Segmentation

The Asia Pacific aortic valve replacement devices market is segmented into product, surgery, end user, and country.

Based on product, the Asia Pacific aortic valve replacement devices market is segmented into sutureless valve and mechanical valve. The sutureless valve held a larger Asia Pacific aortic valve replacement devices market share in 2022.

Based on surgery, the Asia Pacific aortic valve replacement devices market is segmented into minimally invasive surgery and open surgery. The minimally invasive surgery segment held a larger Asia Pacific aortic valve replacement devices market share in 2022.

Based on end user, the Asia Pacific aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment held the largest Asia Pacific aortic valve replacement devices market share in 2022.

Based on country, the Asia Pacific aortic valve replacement devices market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific aortic valve replacement devices market in 2022.

Abbott Laboratories, Artivion Inc, Boston Scientific Corp, Edwards Lifesciences Corp, LivaNova Plc, Medtronic Plc, and Venus MedTech HangZhou Inc, are some of the leading companies operating in the Asia Pacific aortic valve replacement devices market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Aortic Valve Replacement Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Asia Pacific PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
4.4 Pipeline Analysis

5. Asia Pacific Aortic Valve Replacement Devices Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Rising Number of Aortic Valve Replacement Surgeries
- 5.1.2 Increasing Demand for Minimally Invasive Techniques
5.2 Market Restraints
- 5.2.1 Product Recalls
- 5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Market Opportunities
- 5.3.1 Advancements in Aortic Valve Replacement Devices
5.4 Future Trends
- 5.4.1 Increasing Number of Clinical Studies
5.5 Impact Analysis:

6. Aortic Valve Replacement Devices Market - Asia Pacific Market Analysis

6.1 Asia Pacific Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 - by Product

7.1 Overview
7.2 Asia Pacific Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Mechanical Valve
- 7.3.1 Overview
- 7.3.2 Mechanical Valve: Asia Pacific Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Sutureless Valve
- 7.4.1 Overview
- 7.4.2 Sutureless Valve: Asia Pacific Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 - by Surgery.

8.1 Overview
8.2 Asia Pacific Aortic Valve Replacement Devices Market Revenue Share, by Surgery, 2022 & 2030 (%)
8.3 Open Surgery
- 8.3.1 Overview
- 8.3.2 Open Surgery: Asia Pacific Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Minimally Invasive Surgery
- 8.4.1 Overview
- 8.4.2 Minimally Invasive Surgery: Asia Pacific Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 - by End User.

9.1 Overview
9.2 Asia Pacific Aortic Valve Replacement Devices Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals & Clinics
- 9.3.1 Overview
- 9.3.2 Hospitals & Clinics: Asia Pacific Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgery Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgery Centers: Asia Pacific Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Asia Pacific Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Aortic Valve Replacement Devices Market - Country Analysis

10.1 Asia Pacific: Aortic Valve Replacement Devices Market
- 10.1.1 Overview
- 10.1.2 Asia Pacific: Aortic Valve Replacement Devices Market, by Country, 2022 & 2030 (%)
  - 10.1.2.1 China: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 China: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.3 China: Aortic Valve Replacement Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.1.2.1.4 China: Aortic Valve Replacement Devices Market, by Surgery, 2020-2030 (US$ Million)
    - 10.1.2.1.5 China: Aortic Valve Replacement Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.2 Japan: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Japan: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.3 Japan: Aortic Valve Replacement Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.1.2.2.4 Japan: Aortic Valve Replacement Devices Market, by Surgery, 2020-2030 (US$ Million)
    - 10.1.2.2.5 Japan: Aortic Valve Replacement Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.3 India: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 India: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.3 India: Aortic Valve Replacement Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.1.2.3.4 India: Aortic Valve Replacement Devices Market, by Surgery, 2020-2030 (US$ Million)
    - 10.1.2.3.5 India: Aortic Valve Replacement Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.4 Australia: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Australia: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.3 Australia: Aortic Valve Replacement Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.1.2.4.4 Australia Pacific Aortic Valve Replacement Devices Market, by Surgery, 2020-2030 (US$ Million)
    - 10.1.2.4.5 Australia Aortic Valve Replacement Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.5 South Korea: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 South Korea: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.3 South Korea: Aortic Valve Replacement Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.1.2.5.4 South Korea Aortic Valve Replacement Devices Market, by Surgery, 2020-2030 (US$ Million)
    - 10.1.2.5.5 South Korea Aortic Valve Replacement Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.6 Rest of Asia Pacific: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Asia Pacific: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.3 Rest of Asia Pacific: Aortic Valve Replacement Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.1.2.6.4 Rest of Asia Pacific Aortic Valve Replacement Devices Market, by Surgery, 2020-2030 (US$ Million)
    - 10.1.2.6.5 Rest of Asia Pacific Aortic Valve Replacement Devices Market, by End User, 2020-2030 (US$ Million)

11. Asia Pacific Aortic Valve Replacement Devices Market Industry Landscape

11.1 Overview
11.2 Growth Strategies in Asia Pacific Aortic Valve Replacement Devices Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Key Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Medtronic Plc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Boston Scientific Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 LivaNova Plc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Edwards Lifesciences Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Artivion Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Venus MedTech HangZhou Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms